DSM-Firmenich Looks To Women's Health and Postbiotics As Immunity Demand Remains Weak

 
• By Tom Gallen

To counteract falling sales due to weaker immunity supplement demand post-pandemic, ingredients firm DSM-Firmenich is investing in innovation in the increasingly popular women's health and postbiotics product categories. 

Finger pushing innovation button
• Source: Shutterstock

More from Ingredients & Safety

More from HBW Insight